• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Insulclock:一种新型胰岛素输送优化和跟踪系统。

Insulclock: A Novel Insulin Delivery Optimization and Tracking System.

机构信息

1 Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.

2 Insulcloud S.L. (B87131454), Madrid, Spain.

出版信息

Diabetes Technol Ther. 2019 Apr;21(4):209-214. doi: 10.1089/dia.2018.0361. Epub 2019 Mar 21.

DOI:10.1089/dia.2018.0361
PMID:30896261
Abstract

BACKGROUND

Achieving and maintaining controlled glycemic levels are challenging in people with insulin-treated diabetes mellitus, suboptimal insulin injections being the main obstacle to treatment success.

METHODS

This research article presents the main functionalities and performance tests on Insulclock, an electronic device plugged into insulin pens and connected with a smartphone app to improve insulin management. Insulclock tracks the date, time of day, dose, type of insulin, temperature, and duration of insulin injections. Information is stored in the device memory and is available for analysis by patients and health care providers. Insulclock device also has a reminder system with visual and acoustic alerts to reduce insulin omissions and mistiming.

RESULTS

The main performance tests reveal that Insulclock can detect seven types of insulin pens with a 97% correct classification rate. Among 556 injections, most of the doses were accurately detected (deviation = 0), with relative errors ranging from 3% to 7% across different dosages. The duration of injections recorded by this device strongly correlated with that detected by an external chronometer (R = 0.99, root-mean-square deviation [RMSD] = 0.39). Moreover, the precision of the temperature sensor was evidenced by high correlation of temperatures detected by Insulclock and by an external thermometer (Pearson's R = 0.90, RMSD = 0.45).

CONCLUSIONS

Insulclock is a novel device capable of tracking dosing, timing, and missing insulin injections. The promising capabilities it offers for diabetes mellitus self-management may help health care providers, researchers, and insulin users avoid frequent errors in insulin administration.

摘要

背景

对于接受胰岛素治疗的糖尿病患者来说,实现并维持血糖控制水平具有挑战性,而胰岛素注射不规范是治疗成功的主要障碍。

方法

本研究文章介绍了电子设备 Insulclock 的主要功能和性能测试,该设备可插入胰岛素笔并与智能手机应用程序连接,以改善胰岛素管理。Insulclock 可跟踪日期、时间、剂量、胰岛素类型、温度和胰岛素注射持续时间。信息存储在设备内存中,可供患者和医疗保健提供者分析。Insulclock 设备还具有提醒系统,包括视觉和听觉警报,以减少胰岛素遗漏和时间错误。

结果

主要性能测试表明,Insulclock 可以检测七种类型的胰岛素笔,分类准确率为 97%。在 556 次注射中,大多数剂量都被准确检测到(偏差=0),不同剂量的相对误差在 3%至 7%之间。该设备记录的注射持续时间与外部计时器检测到的时间高度相关(R=0.99,均方根偏差[RMSD]=0.39)。此外,Insulclock 检测到的温度与外部温度计检测到的温度高度相关,证明了温度传感器的精度(Pearson's R=0.90,RMSD=0.45)。

结论

Insulclock 是一种能够跟踪剂量、时间和遗漏胰岛素注射的新型设备。它在糖尿病自我管理方面具有广阔的应用前景,可能有助于医疗保健提供者、研究人员和胰岛素使用者避免胰岛素给药过程中的常见错误。

相似文献

1
Insulclock: A Novel Insulin Delivery Optimization and Tracking System.Insulclock:一种新型胰岛素输送优化和跟踪系统。
Diabetes Technol Ther. 2019 Apr;21(4):209-214. doi: 10.1089/dia.2018.0361. Epub 2019 Mar 21.
2
Efficacy of in Patients with Poorly Controlled Type 1 Diabetes Mellitus: A Pilot, Randomized Clinical Trial.在血糖控制不佳的 1 型糖尿病患者中的疗效:一项初步的、随机临床试验。
Diabetes Technol Ther. 2020 Sep;22(9):686-690. doi: 10.1089/dia.2019.0427. Epub 2020 Mar 5.
3
A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice.一种新型的基于笔的支持蓝牙的胰岛素输送系统,具备胰岛素剂量跟踪和建议功能。
Expert Opin Drug Deliv. 2017 May;14(5):697-703. doi: 10.1080/17425247.2017.1313831. Epub 2017 Apr 10.
4
Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review.联网胰岛素笔系统的临床、经济和患者报告获益:系统文献回顾。
Adv Ther. 2023 May;40(5):2015-2037. doi: 10.1007/s12325-023-02478-1. Epub 2023 Mar 16.
5
Analysis of patient satisfaction with a prefilled insulin injection device in patients with type 1 and type 2 diabetes.1型和2型糖尿病患者对预填充胰岛素注射装置的满意度分析。
J Diabetes Sci Technol. 2011 Sep 1;5(5):1235-7. doi: 10.1177/193229681100500532.
6
Insulin delivery by injection in children and adolescents with diabetes.儿童和青少年糖尿病患者的胰岛素注射输送。
Pediatr Diabetes. 2011 Aug;12(5):518-26. doi: 10.1111/j.1399-5448.2010.00731.x. Epub 2011 Apr 11.
7
Considerations for diabetes: treatment with insulin pen devices.关于糖尿病的考虑因素:胰岛素笔装置治疗。
Am J Ther. 2013 Nov-Dec;20(6):694-702. doi: 10.1097/MJT.0b013e318217a5e3.
8
Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals.评估新型预填充胰岛素笔(FlexTouch Degludec U100/U200)在糖尿病患者和医疗保健专业人员中的易用性和偏好性,与 SoloSTAR 胰岛素笔相比。
Expert Opin Drug Deliv. 2014 Sep;11(9):1381-9. doi: 10.1517/17425247.2014.927438. Epub 2014 Jun 12.
9
Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents, and health care professionals.用于胰岛素注射的诺和笔Echo®:儿科患者、其父母及医护人员对其易用性、功能性和偏好的比较
J Diabetes Sci Technol. 2010 Nov 1;4(6):1468-75. doi: 10.1177/193229681000400622.
10
Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.在临床环境中评估的索诺星笔(SoloSTAR)和优伴笔(FlexPen)的剂量准确性。
Diabetes Technol Ther. 2009 Sep;11(9):609-13. doi: 10.1089/dia.2009.0016.

引用本文的文献

1
Evaluating the usability of Diactive-1: mHealth for personalized exercise and education in children and adolescents with type 1 diabetes.评估Diactive-1的可用性:用于1型糖尿病儿童和青少年个性化运动与教育的移动健康应用
Mhealth. 2025 Mar 10;11:16. doi: 10.21037/mhealth-24-63. eCollection 2025.
2
Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Connected Insulin Cap-Based Real-World Study.根据晚餐时间、速效胰岛素以及基础胰岛素和速效胰岛素类型的夜间血糖谱:一项基于胰岛素帽的真实世界研究。
Biomedicines. 2024 Jul 18;12(7):1600. doi: 10.3390/biomedicines12071600.
3
Advantages and disadvantages of connected insulin pens in diabetes management.
糖尿病管理中胰岛素笔联网的利弊
Endocr Connect. 2023 Sep 27;12(11). doi: 10.1530/EC-23-0108. Print 2023 Nov 1.
4
Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN).连体胰岛素笔和笔帽:西班牙内分泌与营养学会(SEEN)糖尿病领域专家的建议
Diabetes Ther. 2023 Jul;14(7):1077-1091. doi: 10.1007/s13300-023-01417-1. Epub 2023 May 15.
5
Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review.联网胰岛素笔系统的临床、经济和患者报告获益:系统文献回顾。
Adv Ther. 2023 May;40(5):2015-2037. doi: 10.1007/s12325-023-02478-1. Epub 2023 Mar 16.
6
Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review.解决青光眼患者低依从性的设备和治疗方法:一项叙述性综述
J Clin Med. 2022 Dec 24;12(1):151. doi: 10.3390/jcm12010151.
7
Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial.带连接功能的胰岛素笔帽对未控制 1 型糖尿病患者的疗效:一项多中心随机临床试验。
Diabetes Care. 2023 Jan 1;46(1):206-208. doi: 10.2337/dc22-0525.
8
The Review of Insulin Pens-Past, Present, and Look to the Future.胰岛素笔的回顾——过去、现在和未来展望。
Front Endocrinol (Lausanne). 2022 Mar 8;13:827484. doi: 10.3389/fendo.2022.827484. eCollection 2022.
9
Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial.智能胰岛素笔帽管理未控制 2 型糖尿病患者的疗效:一项随机交叉试验。
J Diabetes Sci Technol. 2023 Jan;17(1):201-207. doi: 10.1177/19322968211033837. Epub 2021 Jul 22.
10
Digital Diabetes Management: A Literature Review of Smart Insulin Pens.数字糖尿病管理:智能胰岛素笔的文献综述。
J Diabetes Sci Technol. 2022 May;16(3):587-595. doi: 10.1177/1932296820983863. Epub 2021 Jan 11.